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ABSTRACT 
BACKGROUND AND OBJECTIVE: P19 carcinoma stem cells are able to differentiate into embryonic cells with 
three germ layers. Given the fact that differentiated cells can reduce complications associated with degenerative 
diseases of the nervous system, in this study, we aimed to investigate the differentiation of P19 stem cells into neuronal 
cells under the influence of royal jelly. 
METHODS: In this basic-applied research, embryoid bodies, prepared in P19 cell suspension culture, were transferred 
to gelatinized containers and classified in six groups, receiving 25, 50, 100, 150, 200, and 300 mg/ml of royal jelly, 
respectively; five wells were allocated to each group of cells. Morphological evaluation of cell differentiation was 
performed via cresyl violet staining. Also, immunofluorescence technique was used to track the expression of neuronal 
marker proteins such as synaptophysin and β-tubulin III. Finally, the findings were analyzed. 
FINDINGS: The present findings showed that cells exposed to royal jelly responded positively to specific staining of 
nerve cells. In groups receiving different concentrations of royal jelly, the mean percentage of cell differentiation was 
significantly higher than the negative control group (9±2.3). The highest percentage of cell differentiation was observed 
in groups treated with 200 and 300 mg/ml of royal jelly, respectively (98±4.8 and 99.3±2.2, respectively) (p<0.05). 
Based on the findings, the mean percentage of cell differentiation in the group receiving 200 mg/ml of royal jelly was 
not significantly different from the group receiving a concentration of 300 mg/ml.  
CONCLUSION: The results of the present study showed that P19 cells are able to differentiate into neuronal cells, and 
therefore, they could be used in cell-based therapy for neurological diseases. 
KEY WORDS: Carcinomatous stem cells, Differentiation of neural stem cells, Neural markers.
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Introduction 
Degenerative diseases of the nervous system, such 
as Alzheimer's disease, are caused by the degeneration 
of nerve cells and aggregation of toxic proteins in the 
central nervous system (1). So far, various treatment 
methods, e.g., decreasing the level of accumulated 
proteins, have been proposed, which involve reducing 
the blood-brain barrier permeability for the treatment 
of these disorders (2). Cell-based therapy, which 
incorporates the use of stem cell differentiation into 
neurons, is one of the methods which has been 
highlighted in scientific communities in recent years. 
So far, differentiation of various stem cells (e.g., 
embryonic stem cells), triggered by different factors, 
has been evaluated in multiple studies (3).  
In general, according to the literature, neural cells 
can be produced through the differentiation of human 
and mouse embryonic stem cells (4). P19 cells are 
multipotent, embryonic carcinoma cell lines, which 
can grow in a serum medium. These cells can be 
triggered to differentiate into all three lineages, i.e., 
mesoderm, endoderm, and ectoderm (5). When these 
cells are exposed to retinoic acid, they differentiate in 
the neuroectoderm, and consequently, neurons and 
glial cells fill the medium (6).  
Several studies have been conducted on the 
adhesion of retinoic acid-exposed P19 cells to the 
striatum of immunocompromised rats (7). In this 
regard, a previous study, which evaluated the effects of 
deprenyl on the induction of P19 cell differentiation 
into neurons, revealed that this agent could induce 
neuronal differentiation in a dose-dependent manner 
(8). Besides chemical compounds which are used to 
control and reduce neurological complications, a 
number of natural compounds are used by indigenous 
people to manage and treat neurological diseases (6). 
Royal jelly is one of the substances with protective and 
anti-apoptotic effects on nerve cells. It is a viscous 
jelly substance, with a milk-white or pale yellowish 
color, a characteristic odor, and unpleasant taste (9, 
10). In a previous study, it was revealed that cells, 
treated with adenosine monophosphate (AMP) N1-
oxide of royal jelly, have the ability to express specific 
proteins of mature nerve cells. In addition, Hattori and 
colleagues showed that AMP N1-oxide in royal jelly 
could enhance the proliferation of progenitor cells and 
neural stem cells (11). Overall, the results of previous 
research in this area suggest that AMP N1-oxide could 
facilitate the production of astrocytes in neural 
progenitor cells by promoting the phosphorylation of 
STAT3 transcription factors. Social and economic 
damages, caused by degenerative diseases of the 
nervous system, are sharply rising in developing 
countries. Therefore, further research is required to 
control the prevalence of these disorders and reduce 
the associated complications. In this study, we aimed 
to induce neuronal phenotype in P19 cells by using 
royal jelly. 
 
 
Methods 
Materials and Methods: In this basic-applied study, 
the effect of royal jelly on the differentiation of P19 
stem cells into neuronal cells was studied under 
laboratory conditions. 
Cell culture: P19 teratocarcinoma cells were used in 
this study. The cells were obtained from the Cell Bank 
of Pasteur Institute of Tehran, Iran and proliferated in 
adhesive culture. Afterwards, the cells were cultured in 
alpha-minimum essential medium (α-MEM) (Gibco, 
Cat. No.: 11900-073), containing 10% fetal bovine 
serum (FBS) (Sigma, Cat. No.: 10270-106), 50 μg/ml 
of penicillin (Sigma, Cat No.: P3032), and 50 μg/ml of 
streptomycin (Sigma, Cat No.: S1277). The first step 
in the induction of differentiation is the formation of 
embryoid bodies. For this propose, P19 cells were 
cultured for 24 h in Petri dishes with no adhesive 
properties. The obtained embryoid bodies were 
transferred to gelatinized 12-well Petri dishes for cell 
culture. Afterwards, they were exposed to 25, 50, 100, 
150, 200, and 300 mg/ml of royal jelly, respectively. 
For morphological evaluation of cell differentiation, 
specific staining of nerve cells was performed, using 
cresyl violet (Sigma, Cat. No.: 234-043-3).  
The stained cells were counted in order to 
determine the optimal concentration of royal jelly, 
which could trigger the differentiation of more cells 
into neuronal cells. Moreover, a squared graticule was 
used to count neuronal cells which were stained purple 
with cresyl violet. The immunofluorescence technique 
was used to track the expression of specific markers of 
neuronal cells in differentiated cells. In this study, we 
used primary monoclonal β-tubulin III (Abcam, 
ab7751) and primary monoclonal synaptophysin 
(Abcam, San Francisco, CA, ab8049) antibodies. Also, 
fluorescein isothiocyanate-conjugated immunoglobulin 
G (IgG) (Sigma, Cat. No.: F9137) was used as the 
secondary antibody.  
Preparation of different concentrations of royal 
jelly: Royal jelly was purchased from beekeepers in 
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Shahrekord, Iran and mixed with phosphate-buffered 
saline (PBS) at a ratio of 0.025. The mixture was 
slowly shaken overnight at 4°C in an incubator; then, it 
was centrifuged at 12,000 g for 10 min at 4°C. In the 
next step, the supernatant was collected after 
centrifugation and its concentration was determined by 
Bradford assay. Finally, by using the culture medium, 
concentrations of 25, 50, 100, 150, 200, and 300 
mg/ml were prepared, respectively.  
Preparation of embryoid bodies: The first step in the 
induction of stem cell differentiation is the formation 
of embryoid bodies. For this purpose, P19 cells were 
cultured for 24 h in Petri dishes with no adhesive 
properties. Then, embryoid bodies were transferred to 
gelatinized six-well Petri dishes for cell culture. The 
cultured cells were divided into seven groups, each 
exposed to 0, 25, 50, 100, 150, 200, and 300 mg/ml of 
royal jelly, respectively. After 24 h, the culture 
medium was changed and the cells were cultured in a 
medium containing 10% serum for two weeks; it 
should be noted that the cell culture medium was 
replaced in all groups every two days. Neuronal 
phenotypes appeared in the cultured cells within ten 
days following the treatment. 
Cresyl violet staining: Cresyl violet staining was used 
to evaluate the morphology of differentiated cells. For 
this purpose, the cells were washed with PBS and then 
fixated with 4% paraformaldehyde. Cellular hydration 
was performed in a solution containing ethanol and 
acetic acid. Afterwards, the cells were washed three 
times with PBS and incubated for 10 min in a mixture 
containing cresyl violet (0.25%; Sigma, Cat No.: 234-
043-3), glacial acetic acid (0.8), sodium acetate (0.6 
mM), and water (100 ml). Finally, the cells were 
washed with PBS and the cell plates were mounted on 
a slide, using Canada Balsam glue. 
Determination of the optimal concentration of royal jelly: 
The stained cells were counted in order to determine 
the best concentration of royal jelly, which could 
differentiate more cells into neuronal cells. To count 
neuronal cells which were stained purple with cresyl 
violet, a squared graticule was used. For this purpose, 
five fields of view in the light microscope were 
randomly evaluated at 20X magnification for each sample.  
Immunofluorescence technique:Immunofluorescence 
technique was employed to track the expression of 
neural cell markers within differentiated cells. In this 
study, primary β-tubulin and synaptophysin antibodies 
were used; also, conjugated IgG antibody was used as 
the secondary antibody. To perform immunofluorescence, 
cells exposed to royal jelly were incubated for 30 min 
with 4% paraformaldehyde solution. Following 
fixation, the cells were washed three times with PBS. 
The cells were then incubated using a blocking 
solution containing 0.03% Triton X100 and 0.010 of 
normal goat serum (Sigma, Cat. No.: G9023:NGS) in 
PBS for 30 min at 37°C. These cells were incubated 
for 2 h with the primary antibodies at 37°C. Moreover, 
after washing the cells with PBS, they were incubated 
for 2 h with secondary antibodies. Finally, after 
washing the cells with PBS, glycerol (0.070) was used 
to mount the lamellae on the slide. By using the 
microscope, immunofluorescence confirmed β-tubulin 
and synaptophysin expression in differentiated cells.  
Statistical analysis: Statistical analysis was 
performed, using SPSS. Kolmogorov-Smirnov test was 
used to check the normal distribution of the data. To 
assess the difference between the groups, analysis of 
variance (ANOVA) and Duncan's post-hoc tests were 
performed and p<0.05 was considered statistically 
significant.  
 
 
Results 
Morphological examination: Embryoid bodies were 
cultured after 24 h of exposure to royal jelly for 10 
days. The proliferating cells were emitted from the 
embryoid bodies (fig 1).   
 
 
 
 
 
 
 
 
Figure 1. Photomicrograph of P19 cells differentiated 
into neuronal cells by cresyl violet staining. The stained 
nerve cells  
 
Determination of the optimal dose of royal jelly for 
the induction of neuronal phenotypes: Neuron-like 
cells were stained purple, using cresyl violet. The 
mean percentage of neuronal differentiation in groups 
exposed to different concentrations of royal jelly was 
significantly higher than the negative control group 
(9±2.3). Based on the findings, maximum percentage 
of neuronal differentiation was reported in groups 
exposed to 200 and 300 mg/ml of royal jelly, 
respectively (98±4.8 and 99.3±2.2, respectively). The 
percentage of neuronal differentiation significantly 
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increased in groups exposed to 200 and 300 mg/ml of 
royal jelly, compared to cells treated with 25 (21±2.2), 
50 (32±2.3), 100 (71.3±5.3), and 150 mg/ml (83±5.9) 
of royal jelly, respectively (p<0.05). However, as the 
finding revealed, the mean percentage of neuronal 
differentiation in the treatment group receiving 200 
mg/ml of royal jelly was not significantly different 
from the group exposed to 300mg/ml of royal jelly 
(p<0.05) (table 1).  
Confirmation of neuronal cells by immunofluorescence: 
Based on the immunofluorescent assessment of 
differentiated P19 cells, these cells showed a positive 
immune response to β-tubulin III and synaptophysin 
after exposure to royal jelly. Neurons positive for 
synaptophysin and β-tubulin were traced as single cells 
or small clumps of cells (fig 2). 
 
Table 1. Evaluation of the effects of different 
concentrations of royal jelly on the induction of 
neuronal phenotypes in P19 cells 
Percentage of nerve 
induction )PNI( 
(Mean±SD) 
Concentration 
of royal jelly 
(mg/ml) 
21±2.2 b,c,d,e,f* 25 
32±2.3 a,c,d,e* 50 
71.3±5.3 a,b,d,e,f* 100 
83±5.9 a,b,c,e,f* 150 
98±4.8 a,b,c* 200 
99.3±2.2 a,b,c,d* 300 
9±2.3 a,b,c,d,e Control 
          *p<0.05  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Fluorescence microscopic images of 
neuronal cells yielded by the differentiation of P19 
cells under the influence of royal jelly.  
A) Light microscopic image; B) fluorescence microscopic image of 
cells treated with royal jelly and exposed to primary synaptophysin 
antibody; C) light microscopic image; D) fluorescence microscopic 
image of cells treated with royal jelly and exposed to primary β-
tubulin antibody; E) light microscopic image; F) fluorescence 
microscopic image of P19 cells exposed to primary synaptophysin 
antibody by not royal jelly.  
Discussion 
In the present study, ten days after the treatment of 
embryoid bodies with royal jelly, the morphology of a 
number of cells was shown to be similar to that of 
neuronal cells; also, these cells responded positively to 
specific nerve cell staining. The results showed that by 
increasing the concentration of royal jelly, the 
percentage of differentiated cells increased in a dose-
dependent manner.  
These cells expressed specific neuronal markers 
such as synaptophysin and β-tubulin. In various 
studies, P19 cells have been extensively used for 
differentiation into neuronal cells. Chou and 
colleagues showed that differentiation of these cells 
into neuronal cells is influenced by retinoic acid. The 
differentiated cells showed the expression of nestin 
gene on the eighth day, which is a characteristic 
marker of neuronal cells (12).  
Moreover, in a study conducted by Martin and 
colleagues, it was revealed that P19 cells, exposed to 
non-toxic concentrations of dimethyl sulfoxide, 
exhibited a similar morphology to neuronal cells (13). 
In addition, in a previous study, neural differentiation 
of P19 cells, triggered by cell growth factors, was 
reported (14). Furthermore, in a study by 
Bakhshalizadeh et al., deprenyl could induce dose-
dependent neural differentiation in P19 cells 
transfected with green fluorescent protein (GFP). 
Moreover, they revealed that GFP-positive neurons 
derived from P19 cells could migrate in the chick 
embryo nervous system and form synapses with the 
host tissue cells (15). 
In a study by Abdanipour and colleagues, by 
extracting adult stem cells, neuronal differentiation 
was induced by deprenyl at 10-6 and 10-11 mM 
concentrations (16). In addition, Karadeniz et al. 
showed that cisplatin, a chemotherapy agent, could 
result in a significant increase in hepatic cell death. On 
the other hand, royal jelly exerted protective and anti-
apoptotic effects on hepatocytes by increasing the 
production of superoxide dismutase in liver cells (17). 
According to the literature, use of cisplatin might lead 
to the emergence of risk factors and reduce the 
antioxidant activities of superoxide dismutase and 
glutathione peroxidase in the blood. However, 
concomitant use of royal jelly and cisplatin resulted in 
a decline in oxidative stress factors, while increasing 
the level of antioxidants (18). Overall, oxidative stress 
is not only one of the major contributing factors for 
cancer, but is also a major inducer for other disorders 
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(19-28). Hashimoto showed that oral administration of 
royal jelly could increase the expression of 
neurotrophic factors, their receptors, and neural cell 
markers in the hippocampus of adult mice (29). 
Additionally, a study by Hattori and colleagues 
showed that Amp N1-oxide in royal jelly could elicit 
neuronal differentiation in PC12 cells and trigger an 
increase in phosphorylation and astrocyte-specific 
transcription factors (30). In conclusion, the present 
findings suggested P19 cell line as an appropriate and 
cost-effective source for studying the effects of various 
factors involved in the growth and differentiation of 
neurons in vitro; moreover, P19 cells could be 
regarded as an interesting model for mass production 
of neural cells. The results of this study also showed 
that royal jelly could trigger the differentiation of P19 
stem cells into neuronal cells. 
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